1,720,972 research outputs found
RAMEDIS: Vernetzte Forschung am Beispiel angeborener Stoffwechselerkrankungen.
No full textTöpel T, Mischke U, Scheible D, Trefz F, Hofestädt R. RAMEDIS: Vernetzte Forschung am Beispiel angeborener Stoffwechselerkrankungen. Informatik, Biometrie und Epidemiologie in Medizin und Biologie. 2002;33(2 - 3):79-80
Supporting genotype-phenotype correlation with the rare metabolic diseases database Ramedis
No full textTöpel T, Scholz U, Mischke U, Scheible D, Hofestädt R, Trefz F. Supporting genotype-phenotype correlation with the rare metabolic diseases database Ramedis. Silico Biology. 2002;2:36
Harnstoffzykluserkrankungen und Organoazidämien: Aufnahme in das erweiterte Neugeborenen-Screening?
No full textTrefz FK, Scheible D, Frauendienst-Egger G, et al. Harnstoffzykluserkrankungen und Organoazidämien: Aufnahme in das erweiterte Neugeborenen-Screening? Pädiatrie hautnah,. 2005;17(8):19-20
www.ramedis.de: Database for long term follow up of patients with rare metabolic diseases
No full textTrefz FK, Töpel T, Scheible D, Frauendienst-Egger G, Hofestädt R. www.ramedis.de: Database for long term follow up of patients with rare metabolic diseases. JOURNAL OF INHERITED METABOLIC DISEASE. 2006;29(Suppl. 1):84
Expanded newborn screening: Long term follow up of 25 patients with organic acidemias and urea cycle disorders
No full textTrefz FK, Töpel T, Scheible D, Frauendienst-Egger G, Hofestädt R. Expanded newborn screening: Long term follow up of 25 patients with organic acidemias and urea cycle disorders. JOURNAL OF INHERITED METABOLIC DISEASE. 2006;29(Suppl. 1):84
METAGENE and RAMEDIS: databases for metabolic diseases and patients with inborn errors on metabolism
No full textTrefz F, Scheible D, Götz H, Töpel T, Hofestädt R, Frauendienst-Egger G. METAGENE and RAMEDIS: databases for metabolic diseases and patients with inborn errors on metabolism. Journal of Inherited Metabolic Disease. 2008;31:289
Expanded newborn screening: Long-term follow up of 63 patients screened by tandem mass spectrometry
No full textScheible D, Töpel T, Frauendienst-Egger G, Hofestädt R, Wallner S, Trefz FK. Expanded newborn screening: Long-term follow up of 63 patients screened by tandem mass spectrometry. JOURNAL OF INHERITED METABOLIC DISEASE. 2007;30(Suppl. 1):3
RAMEDIS - Rare Metabolic Diseases Publishing Tool for Genotype-Phenotype Correlation
No full textHofestädt R, Mischke U, Scholz U, Töpel T, Scheible D, Trefz FK. RAMEDIS - Rare Metabolic Diseases Publishing Tool for Genotype-Phenotype Correlation. In: Patel VL, ed. Proceedings of the 10th World Congress on Medical Informatics. Studies in health technology and informatics. Vol 84. Amsterdam: IOS Press; 2001: 970-974
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
